title: Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?
authors.forename: Rong-Nan
authors.initials: RN
authors.lastname: Chien
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000517:prevention & control* / Q000628:therapy*; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D005260:Female; D006147:Guanine / Q000031:analogs & derivatives*; D006498:Hepatectomy; D017325:Hepatitis B Vaccines; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000517:prevention & control*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000517:prevention & control* / Q000628:therapy*; D008297:Male
chemical_list: D000998:Antiviral Agents; D017325:Hepatitis B Vaccines; D019259:Lamivudine; D006147:Guanine